What You Should Know About Injectable Weight-Loss Drugs

Overweight is a chronic medical condition characterized by excess body fat. Obesity is usually described as having a BMI of 30 or greater. This situation comes with a lot of health risks, like a higher chance of getting type 2 diabetes, heart disease, some cancers, and other long-term illnesses.

Injectable weight-loss drugs have become a valuable way to deal with the complicated health problem of rising obesity around the world. They play a crucial role in comprehensive obesity treatment plans.

People who take these drugs are supposed to follow medical weight loss patterns and make lifestyle changes, like eating less and exercising more, to help them reach and maintain a better weight.

Even though they are not a magic bullet, these drugs can help people who are overweight a lot, primarily when other methods have not worked.

Types of Injectable Weight-Loss Drugs

1. Wegovy (Semaglutide)

Wegovy injection helps people who are considered overweight or obese and have at least one loss-related medical condition continue a weight loss. Wegovy belongs to a class of drugs called GLP-1 receptor agonists.

Mechanism of Action

Semaglutide binds to and turns on the GLP-1 receptor, similar to how the natural GLP-1 hormone works.
It acts on appetite centers in the brain, reducing hunger sensations and food cravings.
This approach reduces the rate at which the intestines drain into the small intestine, making one feel heavier.
Insulin Secretion increases the release of glucose-dependent insulin from beta cells in the pancreas, which makes it easier to control blood sugar.
Glucagon Suppression lowers the release of glucagon from pancreatic alpha cells, which helps keep blood sugar levels steady.
This drug may affect the brain’s reward system, making eating high-calorie foods less enjoyable.

Related, Get Answers to Your Common Questions About Semaglutide for Weight Loss

Dosage and Administration

Route: Subcutaneous injection
Frequency: Once weekly
Intravenous Sites: pelvic, leg, or upper limb.
Medication increase schedule:

Week 1-4: 0.25 mg once weekly
Week 5-8: 0.5 mg once weekly
Week 9-12: 1 mg once weekly
Week 13-16: 1.7 mg once weekly
Week 17 and onward: 2.4 mg once weekly (maintenance dose)

The whole length of dosage escalation is 16-20 weeks.

Missed Doses: When you miss a dosage and your next recommended dose is over a week away, take it right away as possible.

2. Saxenda (Liraglutide)

Individuals with a body mass index (BMI) of 30 or above are considered fat, while those with a BMI of 27 or greater are classified as overweight. Liraglutide for weight loss is a drug that is prescribed to help these people reduce weight.

Mechanism of Action

Liraglutide binds to the GLP-1 receptor and turns it on, like the body’s GLP-1 hormone.
It acts on the brain’s appetite regions, reducing appetite and increasing sensations of fullness.
It slows digestion, contributing to decreased meal consumption and a while fullness.
It increases insulin release from cardiac beta cells in a way dependent on glucose.
This limits insulin production, which helps control glucose levels.
Some research studies show that liraglutide may help protect neurons, but this is different from how it works to help you lose weight.

Dosage and Administration

Route: Subcutaneous injection
Frequency: Once daily
Injection sites: Abdomen, thigh, or upper arm
Dose Escalation Schedule

Week 1: 0.6 mg daily
Week 2: 1.2 mg daily
Week 3: 1.8 mg daily
Week 4: 2.4 mg daily

The overall period of dosage increase is four weeks.

Time of administration: May be consumed at any point of the day, irrespective of meals.
Missed doses: When a dose is skipped, follow the once-daily routine according to instructions with the following scheduled dose. Avoid double or enhance the dose to make up for the missed dose.

3. Zep bound (Tirzepatide)

Zep bound (Tirzepatide) Zep bound is an intriguing injectable medication that has been authorized for use in obese or overweight people who have a minimum of one weight-related health issue. It is fantastic because it stimulates the GLP-1 and the GIP (glucose-dependent insulinotropic polypeptide receptors).

Mechanism of Action

Tirzepatide activates both GLP-1 and GIP receptors, providing a synergistic effect on weight loss and metabolic control.
The dual action may lead to more potent appetite suppression than GLP-1 receptor agonists alone.
This ingredient slows down the stomach’s emptying, making you feel fuller and less hungry.
GIP activation may enhance insulin sensitivity in peripheral tissues.
Some studies show that tripeptide may increase energy use, but this effect needs more research.
It might lower the chance of heart disease, but long-term studies are still being done.

Dosage and Administration

Route: Subcutaneous injection
Frequency: Once weekly
Injection sites: abdomen, leg, or upper limb
Dose Escalation Schedule

Weeks 1-4: 2.5 mg once weekly
Weeks 5-8: 5 mg once weekly
Weeks 9-12: 7.5 mg once weekly
Weeks 13-16: 10 mg once weekly
Week 17 and onward: 15 mg once weekly (maximum recommended dose)

Total duration of dose escalation: 16-20 weeks

Missed doses: If an injection goes by and the following scheduled dosage is over a week away, take it as quickly as practical. Once it is less than four days until the next regular dose, disregard the missed dosage and give the next dose on the regularly scheduled day.

Effectiveness and Safety of Injectable Weight-Loss Drugs

Weight Loss Outcomes

Injectable weight-loss drugs can work very differently for different people and drug groups. Users may expect to lose 5-10% of their original weight throughout their initial year of therapy. Research investigations have shown that many people who take newer drugs, such as semaglutide and tripeptide, shed a mean of 15 to 20% of their total weight.

Factors affecting individual response include:

Genetic predisposition
Starting weight and BMI
Adherence to drug regimen
Concurrent lifestyle modifications
Presence of other health conditions

Side Effects and Risks

While injectable weight-loss drugs can be practical tools in managing obesity, they are not without risks. Knowing the potential negative consequences is essential for people thinking about these drugs.

Common Side Effects

Gastrointestinal issues (nausea, diarrhea, constipation)
Headaches
Dizziness
Fatigue
Dry mouth

Serious Potential Side Effects

Increased blood pressure and heart rate (particularly with stimulant medications).
Mood changes or depression.
Pancreatitis (rare but associated with some GLP-1 agonists).
Gallbladder problems.
Kidney stones (associated with long-term use of some drugs).

Contraindications and Precautions

Pregnancy or breastfeeding.
History of eating disorders.
Uncontrolled high blood pressure.
Cardiovascular disease.
Glaucoma (for certain medications).
Hyperthyroidism.

Long-Term Use and Weight Maintenance

Weight-loss drugs that are injected are usually thought of as long-term solutions for people who are overweight or obese. The majority of individuals have to keep taking medication to keep their weight decrease. Based on studies, stopping these drugs often causes people to regain weight. This shows how important it is to see obesity as a long-term disease that needs ongoing care.

Considerations for Injectable Weight-Loss Drugs

Lifestyle Changes and Combination Therapy

Injectable weight-loss drugs are most effective when used in combination with lifestyle modifications. A comprehensive weight management plan should include:

A balanced, calorie-controlled diet
Regular physical activity (at least 150 minutes of moderate impact exercise per week)
Behavioral changes to address eating habits and triggers

Many medical professionals propose combining drugs with behavioral therapies or psychotherapy. This method can help people come up with long-term plans to control their weight and deal with psychological issues that might be making them gain weight.

Patient Selection and Monitoring

Only some people who want to lose weight are suitable candidates for injectable weight-loss drugs. Healthcare providers typically consider these medications for patients who:

Maintain an overall body mass index (BMI) of at least 30 (obesity).
Possessing a body mass index of 27 or greater (overweight) and a minimum of one obesity-related illness.

Once prescribed, regular monitoring is essential. This typically includes:

Regular check-ups to assess weight loss progress
Monitoring of blood pressure and heart rate
Blood tests to check for potential side effects or complications
Adjustments to drug dosage or type as needed

Get Expert Advice on Injectable Drugs Today!

Injectable weight-loss drugs can be very helpful in managing weight for people who have had trouble with traditional weight-loss methods. When these drugs are combined with lifestyle changes, they can help people lose significant weight and get better from health problems related to obesity.

Yet, it is vital to comprehend that those therapies are not magical solutions. They can have adverse effects and hazards, and their efficacy varies from person to individual. Long-term use is often needed to maintain weight loss, and withdrawal can result in weight gain.

If you’re thinking about using injectable weight-loss drugs, talk to our medical professionals. They can look at your situation, speak to you about the possible benefits and risks, and help you determine the best way to treat yourself.

Remember that the path to long-term weight loss is often complicated and multifaceted, and it takes a complete plan that includes both the physical and behavioral parts of weight management.

Our Team